Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium uptake protein 3, mitochondrial (MICU3) is a calcium-binding regulatory protein localized to the mitochondrial intermembrane space and is a component of the mitochondrial calcium uniporter complex, which modulates mitochondrial calcium uptake[1][2][4]. MICU3 often forms a heterodimer with MICU1, enhancing mitochondrial calcium uptake, especially in neuronal presynapses and cardiac myocytes[4][5]. Experimental findings show that MICU3 is necessary for proper physiological mitochondrial calcium regulation: its overexpression promotes increased calcium uptake and can trigger cardiac hypertrophy with reduced heart function, while knockout reduces mitochondrial calcium responses to adrenergic stimulation[1][2]. Decreased MICU3 protein/expression is observed in human heart failure samples, implicating it in cardiovascular disease processes and as a possible therapeutic target[1][2]. There is no evidence of interacting drugs or use as a direct biomarker outside research settings.
Modulation of mitochondrial calcium uniporter activity (no drugs documented)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium uptake protein 3, mitochondrial (MICU3).